pone.0297852.s012.docx (65.02 kB)
Baseline characteristics.
journal contribution
posted on 2024-02-08, 18:31 authored by Lucy Bolt, Alexandre Speierer, Sylvain Bétrisey, Martina Aeschbacher-Germann, Manuel R. Blum, Baris Gencer, Cinzia Del Giovane, Drahomir Aujseky, Elisavet Moutzouri, Nicolas RodondiLLT = Lipid-lowering treatment, CV = cardiovascular.
(DOCX)
History
Usage metrics
Categories
Keywords
investigate potential subgroupsdifferent age cut99 &# 821197 &# 821191 &# 8211188 &# 821700 &# 8211particularly &# 8805randomized clinical trialsincluded 27 trialsindividual participant dataconfidence interval 0xlink "> lltxlink "> lipidincreased cancer deathsperformed subgroup analysesanalysis increased cancer death&# 8805xlink ">subgroup analysescancer deathsincreased risklowering trialsllt trialsinduce cancercancer mortalitycancer deathusing randomthough lltsystematic reviewsecondary preventionolder adultsmade publiclowering therapycontrol groupscontrol groupcontrol armcochrane centralcause mortality75 years70 years259 participants23 statin23 ),10 ),01 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC